The inclusion of patients in the NeuroEpo clinical trial (CT) in mild and moderate Alzheimer's will begin in Holguín next September, after a period of organization and evaluation in the territory, where the study will be assumed by the Provincial Group of CT and will include a multidisciplinary team of neurologists, psychiatrists, neuropsychologists, among other specialties.

Cuban President Miguel Díaz-Canel highlighted the advances made by Cuban scientists against Alzheimer's disease after announcing the start of clinical trials of the drug NeuralCIM (NeuroEPO).

Four Cuban provinces have shown an open dengue transmission, a complex situation due to high infestation by Aedes Aegypti mosquito, a specialist warned on Tuesday.

Cuba is the nation with the highest number of Covid-19 booster doses administered to its population worldwide, thanks to a staggered vaccination campaign with nationally produced immunogens.